NiXEN reinforces its Investment Team

NiXEN reinforces its investment team and announces the arrival of Steven Barrois as an Associate.  Graduated from Centrale Supélec Scholl and the Imperial College of London, Steven Barrois started its career in the Transaction Services Department of EY in 2013. In 2015, he was promoted as a Senior Consultant in this department where he intervened on buy-side and sell-side financial due...

Read on

NiXEN joins the Initiative Carbone 2020

NiXEN is committed in fighting global warming and has joined the Initiative Carbone 2020 created by the French private equity firms Apax Partners, Ardian, Eurazeo, LBO France and PAI Partners Launched in November 2015, the Initiative Carbone 2020 is the first private equity initiative to manage and reduce greenhouse gas emissions for their portfolio companies. NiXEN joins this initiative, confirming its commitment to meet the objectives set out during the COP21 aiming at reducing global warming. Aware that global warming will significantly impact the economy, and of its responsibility as a long-term shareholder, NiXEN joins this initiative in order to ensure the sustainable...

Read on

NiXEN, founding member of The Alliance for Global Growth

NiXEN team is pleased to announce the creation of The Alliance for Global Growth, a global network of 10 ambitious mid-market Private Equity firms and the first of its kind to span Europe and North America.“We are proud to be one of the founding members of the first transatlantic GPs Alliance: the Alliance for Global Growth. We are sure that this initiative will create new opportunities for our portfolio companies.” Jean-Paul Bernardini, Managing Partner of NiXENInternationalisation is one of the primary growth strategies that the members of the Alliance adopt in order to add value to their portfolios. Through years of experience, they recognise that local knowledge and trusted...

Read on

NiXEN sells its stakes in Labco

NiXEN annonces the selling of its minority stake in Labco to Cinven NiXEN entered Labco’s capital in 2008 as a part of an investment consortium including notably 3i, alongside the company’s founders and independent biologists, in order to support its development and particularly Labco’s ability to be the consolidator of the diagnostics laboratory market in France and Europe. Labco became a pan-European key player with leadership or co-leadership positions in France, Iberia, Italy and Belgium. More recently the group stepped in the United-Kingdom market, were its development perspectives as a subcontractor for public hospital groups are promising. Since 2008, Labco’s turnover...

Read on

Document downloads